General Information of the Compound
| Compound ID |
CP0884854
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-[3-(4-{[6-({(2R)-2-Hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)phenyl]-5,5-dimethyl-2,4-imidazolidinedione acetate salt
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H47N3O8
|
||||||||||||||||||
| Molecular Weight |
601.741
|
||||||||||||||||||
| Canonical SMILES |
CC(=O)O.CC1(C)NC(=O)N(c2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H43N3O6.C2H4O2/c1-30(2)28(37)33(29(38)32-30)25-12-9-11-22(18-25)10-5-8-17-39-16-7-4-3-6-15-31-20-27(36)23-13-14-26(35)24(19-23)21-34;1-2(3)4/h9,11-14,18-19,27,31,34-36H,3-8,10,15-17,20-21H2,1-2H3,(H,32,38);1H3,(H,3,4)/t27-;/m0./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZEYCZRIYUSTZBN-YCBFMBTMSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor